NCT00079053 2023-08-04
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Canadian Cancer Trials Group
Phase 1 Completed
Canadian Cancer Trials Group
GOG Foundation
Children's Oncology Group
Pediatric Brain Tumor Consortium